Literature DB >> 9504332

Genetics of host resistance and susceptibility to intramacrophage pathogens: a study of multicase families of tuberculosis, leprosy and leishmaniasis in north-eastern Brazil.

J M Blackwell1.   

Abstract

Genetic analysis of disease phenotypes segregating in recombinant inbred, congenic and recombinant haplotype mouse strains permitted us to effectively "scan" the murine genome for genes controlling resistance and susceptibility to leishmanial infections. Five major regions were implicated which, because they show conserved synteny with regions of the human genome, immediately provide candidate gene regions for human disease susceptibility genes. A common intramacrophage niche for leishmanial and mycobacterial pathogens, and a similar spectrum of immune response and disease phenotypes, also led to the prediction that the same genes/candidate gene regions might be responsible for genetic susceptibility to mycobacterial infections such as leprosy and tuberculosis. Indeed, one of the murine genes (Nramp1) was identified for its role in controlling a range of intramacrophage pathogens, including leishmanial, salmonella and mycobacterial infections. In recent studies, multicase families of visceral leishmaniasis, tuberculosis and leprosy, from north-eastern Brazil have been analysed to determine the role of these candidate genes/regions in humans. Complex segregation analysis provides evidence for one or two major genes controlling susceptibility to these diseases in this population. Family-based linkage analyses (e.g., combined segregation and linkage analysis; sib-pair analyses) and transmission disequilibrium testing have been used to examine the role of four regions in disease susceptibility and/or immune response phenotypes. Results to date demonstrate: (1) the major histocompatibility complex (MHC:H-2 in mouse, HLA in humans: mouse chromosome 17/human 6p; candidates class II and class III including tumour necrosis factor alpha/beta genes) shows both linkage to, and allelic association with, leprosy per se, but is only weakly associated with visceral leishmaniasis and shows neither linkage to, nor allelic association with, tuberculosis; (2) no evidence for linkage between NRAMP1, the positionally cloned candidate for the murine macrophage resistance gene Ity/Lsh/Bcg (mouse chromosome 1/human 2q35), and susceptibility to tuberculosis or visceral leishmaniasis; (3) the region of human chromosome 17q (candidates NOS2A, SCYA2-5) homologous with distal mouse chromosome 11 is linked to tuberculosis susceptibility; and (4) the "T helper 2" cytokine gene cluster (proximal murine chromosome 11/human 5p; candidates IL4, IL5, IL9, IRF1, CD14) is not linked to human disease susceptibility for any of the three infections, but shows linkage to and highly significant allelic association with ability to mount an immune response to mycobacterial antigens. The demonstration of an allelic association between IL4 and immune response to mycobacterial antigen may provide a genetic explanation for the inverse association recently demonstrated between delayed hypersensitivity T helper 1 responses to mycobacterial antigen and atopic disorder in Japanese children. These studies demonstrate that the "mouse-to-human" strategy, refined by our knowledge of the human immune response to infection, can lead to the identification of important candidate gene regions in humans.

Entities:  

Mesh:

Year:  1998        PMID: 9504332     DOI: 10.1016/s0020-7519(97)00175-6

Source DB:  PubMed          Journal:  Int J Parasitol        ISSN: 0020-7519            Impact factor:   3.981


  9 in total

1.  PROBLEMS IN MANAGEMENT OF KALA AZAR: EXPERIENCE FROM BIHAR.

Authors:  S P Rai; S Bandyopadhyay
Journal:  Med J Armed Forces India       Date:  2011-07-21

2.  Association between the tumor necrosis factor locus and the clinical outcome of Leishmania chagasi infection.

Authors:  Theresa M Karplus; Selma M B Jeronimo; Haeok Chang; Bethany K Helms; Trudy L Burns; Jeffrey C Murray; Adele A Mitchell; Elizabeth W Pugh; Regina F S Braz; Fabiana L Bezerra; Mary E Wilson
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

Review 3.  Leprosy and the human genome.

Authors:  Elizabeth A Misch; William R Berrington; James C Vary; Thomas R Hawn
Journal:  Microbiol Mol Biol Rev       Date:  2010-12       Impact factor: 11.056

4.  Evidence for a link between iron metabolism and Nramp1 gene function in innate resistance against Mycobacterium avium.

Authors:  M S Gomes; R Appelberg
Journal:  Immunology       Date:  1998-10       Impact factor: 7.397

Review 5.  Comparative genomics and host resistance against infectious diseases.

Authors:  S T Qureshi; E Skamene; D Malo
Journal:  Emerg Infect Dis       Date:  1999 Jan-Feb       Impact factor: 6.883

Review 6.  Host genetic factors in American cutaneous leishmaniasis: a critical appraisal of studies conducted in an endemic area of Brazil.

Authors:  Léa Cristina Castellucci; Lucas Frederico de Almeida; Sarra Elisabeth Jamieson; Michaela Fakiola; Edgar Marcelino de Carvalho; Jenefer Mary Blackwell
Journal:  Mem Inst Oswaldo Cruz       Date:  2014-05-27       Impact factor: 2.743

7.  Detection of IS6110 and HupB gene sequences of Mycobacterium tuberculosis and bovis in the aortic tissue of patients with Takayasu's arteritis.

Authors:  María Elena Soto; Ma Del Carmen Ávila-Casado; Claudia Huesca-Gómez; Gilberto Vargas Alarcon; Vicente Castrejon; Virgilia Soto; Sergio Hernandez; Nilda Espinola-Zavaleta; Maite Vallejo; Pedro A Reyes; Ricardo Gamboa
Journal:  BMC Infect Dis       Date:  2012-08-20       Impact factor: 3.090

Review 8.  Leprosy in Denmark 1980-2010: a review of 15 cases.

Authors:  Huma Aftab; Susanne D Nielsen; Ib C Bygbjerg
Journal:  BMC Res Notes       Date:  2016-01-05

9.  Dermotropic Leishmania donovani in Sri Lanka: visceralizing potential in clinical and preclinical studies.

Authors:  K K G D U L Kariyawasam; A Selvapandiyan; H V Y D Siriwardana; A Dube; P Karunanayake; S A S C Senanayake; R Dey; S Gannavaram; H L Nakhasi; N D Karunaweera
Journal:  Parasitology       Date:  2017-11-08       Impact factor: 3.234

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.